You searched for "image"
Bleomycin for conjunctival lymphangioma
This is a retrospective review of 16 eyes which underwent intralesional / sub-conjunctival injections of bleomycin sclerotherapy for conjunctival lymphatic malformations (lymphangiomas). The mean age was 18 (range three to 59 years). Four of the lesions were microcystic and 12...
Investigation into the anatomical differences of eyelashes between Caucasian and Indian specimens
This study investigated the anatomy of human eyelashes through analysis of root depth, angle, and spatial relationship. Four eyelids from Caucasian donors were obtained from fresh donors and four eyelids from Indian donors were obtained from eye bank calls. The...The future of binocular viewing systems?
I recently had the pleasure to visit Vision Engineering’s headquarters and manufacturing facility in Woking, UK. Vision Engineering have built an international reputation for engineering microscopes that provide 3D visualisation without the use of traditional optical eyepieces. Although the company...Orbis named winner of 2023 Amazon Web Services IMAGINE grant for non-profits
Orbis will work with Amazon's cloud computing arm to expand access to artificial intelligence-assisted eye screenings in Asia and Africa.Transferring imaging from primary to secondary care (part 2)
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. In...
Sickle cell maculopathy
This paper reports the result of a prospective study to analyse the prevalence of sickle cell maculopathy (SCM) and its associations with age, sex, genotype, proliferative sickle cell retinopathy (PSR) stage, and the impact on visual acuity (VA). This study...Transferring imaging from primary to secondary care (part 1)
Transferring clinical imaging from high street optometrists to secondary care is an increasingly requested option, especially in the context of the COVID-19 pandemic. A wide variety of solutions exist to allow this, each with their own merits and shortcomings. For...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
